Follicular acneiform eruption induced by imatinib [29]

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 10, 2006, Pages 1368-1370

  Martin J M ^a   Jorda E ^a   Monteagudo, C ^a   Alonso, V ^a   Garcia L ^a   Villalon G ^a  

^a Hospital Clinico Universitario   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR;

ACNE; ADULT; CASE REPORT; CAUCASIAN; CHEEK; CHIN; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; DIARRHEA; DRUG ERUPTION; EAR DISEASE; EYELID EDEMA; FACE ERYTHEMA; FEMALE; FOREHEAD; HISTOPATHOLOGY; HUMAN; LETTER; LICHENOID ERUPTION; MACULOPAPULAR RASH; MUCOSAL DISEASE; MYALGIA; NAUSEA; NOSE EDEMA; PRIORITY JOURNAL; PRURITUS; PSORIASIS; PURPURA; SHOULDER; SKIN BIOPSY; SKIN EXAMINATION; SKIN ULCER; TRUNK; XEROSIS;

ACNE VULGARIS; ADULT; ANTINEOPLASTIC AGENTS; DRUG ERUPTIONS; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; PIPERAZINES; PYRIMIDINES;

EID: 33750315357     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01723.x     Document Type: Letter

References (7)

1. Brouard MC, Prins C, Mach-Pascual S, Saurat JH. Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukaemia. Dermatology 2001; 203: 57-59.
2. Druker BJ, Talpaz M, Resta DJ et al. Efficacy and safety of a specific inhibitor of the bcl-abr tyrosine kinase in chronic myeloid leucemia. N Engl J Med 2001; 344: 1031-1037.
3. Valeyrie L, Bastuji-Garin S, Revuz J et al. Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: A prospective study of 54 patients. J Am Acad Dermatol 2003; 48: 201-206.
4. Roux C, Boisseau-Garsaud AM, Saint-Cyr I, Helenon R, Quist D, Delaunay C. Toxicodermie lichenoide a l'imatinib (Glivec R). Ann Dermatol Venereol 2004; 131: 571-573.
5. Druker BJ, Sawyers CL, Kantarjian H et al. Activity of a specific inhibitor of the bcr-abl tyrosine kinase in the blast crisis of chronic myeloid leukaemia and acute lymphoblastic leukaemia with the Philadelphia chromosome. N Engl J Med 2001; 344: 1038-1042.
6. Van Doorn R, Kirtschig G, Scheffer E, Stoof TJ, Giaccone G. Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor. Br J Dermatol 2002; 147: 598-601.
7. Busam KJ, Capodieci P, Motzer R, Kiehn T, Phelan D, Halpern AC. Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225. Br J Dermatol 2001; 144: 1169-1176.